SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    W. C. Lee, M. Dekoven, J. Bouchard, M. Massoudi, J. Langer, Improved real-world glycaemic outcomes with liraglutide versus other incretin-based therapies in type 2 diabetes, Diabetes, Obesity and Metabolism, 2014, 16, 9
  2. 2
    Qian Li, Abhishek Chitnis, Mette Hammer, Jakob Langer, Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States, Diabetes Therapy, 2014, 5, 2, 579

    CrossRef